Hamps Bio Share Price
25.90+0.00 (+0.00%)
-10.21% past 1 Year
Hamps Bio is engaged in the ethical marketing and distribution of pharmaceutical formulation products (Pharma) across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used
Corporate filings & documents
Announcements
We have attached herewith the annual report for the financial year 2025-26.
2 weeks agoWe have attached herewith the annual report for the financial year 2025-26.
2 weeks agoWe have attached herewith the Annual General Meeting notice for the year 2025-26.
2 weeks agoWe have attached herewith the Annual General Meeting notice for the year 2025-26.
2 weeks agoOutcome of Board Meeting.
3 weeks agoOutcome of Board Meeting.
3 weeks agoCertificate under Reg. 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended 30th June 2026.
1 month agoCertificate under Reg. 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended 30th June 2026.
1 month agoIntimation under Regulation 30(5) of the SEBI LODR
1 month agoIntimation under Regulation 30(5) of the SEBI LODR
1 month agoAppointment of Company Secretary and Compliance officer is attached herewith.
1 month agoAppointment of Company Secretary and Compliance officer is attached herewith.
1 month agoResignation of company secretary is attached herewith.
1 month agoResignation of company secretary is attached herewith.
1 month agoOutcome of Board Meeting dated 06.07.2026 is attached herewith.
1 month agoOutcome of Board Meeting dated 06.07.2026 is attached herewith.
1 month agoPursuant to regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform you that Ms. Komal Jain Company Secretary and Compliance Officer of the company has tendered her resignation vide her letter dated 19th June 2026 which has been accepted today. She will be relieved from the services of the company w.e.f. close of business hours on Tuesday 30th June 2026.
2 months agoPursuant to regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform you that Ms. Komal Jain Company Secretary and Compliance Officer of the company has tendered her resignation vide her letter dated 19th June 2026 which has been accepted today. She will be relieved from the services of the company w.e.f. close of business hours on Tuesday 30th June 2026.
2 months agoRe-appointment of Internal Auditor of Hamps Bio Limited
3 months agoRe-appointment of Internal Auditor of Hamps Bio Limited
3 months agoThe Financial results for the year ended 31-03-2026 are attached herewith.
3 months agoStandalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31 2026 along with Auditors Report thereon is attached herewith.
3 months agoStandalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31 2026 along with Auditors Report thereon is attached herewith.
3 months agoHamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Hamps Bio Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Half Year and Year to date ended March 31 2026 along with the Auditors Report thereon.
3 months agoHamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Hamps Bio Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Half Year and Year to date ended March 31 2026 along with the Auditors Report thereon.
3 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026.
4 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026.
4 months agoDisclosure regarding Closure of Trading Window is attached herewith.
5 months agoDisclosure regarding Closure of Trading Window is attached herewith.
5 months agoUpdate on Acquistion of 100% equity shares of HSDL Innovative Private Limited. This is to inform you that the Company has completed acquisition of 100% paid up equity share capital of HSDL Innovative Private Limited. Consequent to the said acquisition HSDL Innovative Private Limited has become Wholly Owned Subsidary of Hamps Bio Limited w.e.f. 25.03.2026.
5 months agoUpdate on Acquistion of 100% equity shares of HSDL Innovative Private Limited. This is to inform you that the Company has completed acquisition of 100% paid up equity share capital of HSDL Innovative Private Limited. Consequent to the said acquisition HSDL Innovative Private Limited has become Wholly Owned Subsidary of Hamps Bio Limited w.e.f. 25.03.2026.
5 months agoConsidered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
6 months agoConsidered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
6 months agoThe certificate under regulation 74(5) of SEBI (DP) Regulatons 2018 is attached herewith.
7 months agoWe have attached herewith the Scrutinizers Report.Kindly take the same on your record.
9 months agoEnclosed herewith is the outcome of EGM of the company held on Monday 24th November 2025 at the corporate office of the company.
9 months agoUnaudited Financial Results for the Half Year Ended 30.09.2025 is attached herewith.
9 months agoThe Unaudited Financial Results for the half year ended on 30.09.2025 is attached herewith for your reference.
9 months agoHamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited financial results for the half year ended September 30 2025.
9 months agoIntimation for re-scheduling the date of the Board Meeting is attached herewith.
9 months agoHamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Unaudited Financial Results for the Half Year ended September 30 2025.
10 months agoWe hereby submit the Notice of Extra Ordinary General Meeting.
10 months agoAnnouncement for calling Extra Ordinary General Meeting of the company is attached herewith.
10 months agoThe Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 is attached herewith.
10 months agoDisclosure regarding Closure of Trading Window is attached herewith.
11 months agoAnnouncement for Allotment of Bonus Issue is attached herewith.
11 months agoThe Intimation regarding Revised Record Date is attached herewith.
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-09-08
Bonus
1:1
Company details
Registered office
2900/112, G I D C Near Atul Limited Ankleshwar Bharuch Gujarat PIN: 393002 Tel No: 8000006663 Fax No: NULL Email: [email protected] Internet: www.hampsbio.com
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Ravi Baheti, Company Secretary & Compliance Officer
Herrik Shah, Chairman & Managing Director
Herrik Shah, Chairman & Managing Director
Shrenik Shah, Whole Time Director
Pallavi Shah, Non Executive Director
Jinay Palrecha, Non Executive Independent Director
Shivali Rajpurohit, Non Executive Independent Director
Details
BSE 544312
NSE NULL
ISIN INE0QBD01018